THE AMERICAN SOCIETY OF GENE & CELL THERAPY Charity Report

Public IRS 990 nonprofit record

THE AMERICAN SOCIETY OF GENE & CELL THERAPY

EIN 91-1766321 · Birth Defects & Genetic Diseases Research (H20)

What they do

ASGCTS MISSION is to ADVANCE KNOWLEDGE, AWARENESS, and EDUCATION LEADING to THE DISCOVERY and CLINICAL APPLICATION of GENETIC and CELLULAR THERAPIES to ALLEVIATE HUMAN DISEASE.

Before you give

Should I give to this charity?

Easy charity check

Look at where the money went

Of every $100 spent, about $80.10 was reported for mission work. Use the spending picture below and ask what results that work produced.

Plain answer: A tax form cannot prove that a charity is doing good. It can show how the charity says it spent its money—and point out questions you should ask.

Basic facts we verified

IRS warning checkNo IRS revocation warning appears in this data.

Money report from 2024The charity has a recent tax report to read.

They explain their jobThe charity tells us what it is trying to do.

They name their leaders25 people are listed in the latest report.

You can reach themThey list contact information, so you can ask questions.

Money made simple

69.06%of revenue went to mission work80.1% of expenses · Program services

4.86%of revenue went to fundraising5.6% of expenses

$86.19spent for every $100 of revenueRevenue covered expenses this year.

12.27%of revenue went to management and office costs14.2% of expenses

$1.86in assets for every $1 spent this yearSome assets cannot be spent right away.

1.4%of its money came from giftsOther money may come from services or investments.

Ask these three easy questions

Who did you help? Ask for a recent story or report that shows real results.
What will my money do? Ask exactly what your gift will pay for.
Is this really the charity? Give only through its official website or confirmed phone number.

Pay context: The highest compensation shown in this filing is $618,447 for DAVID BARRETT (EXECUTIVE DIRECTOR). Compare pay with organizations of similar size and complexity.

Bottom line: Do not decide from a name, mission statement, or tax status alone. Look at where the money went, then ask what changed, who was helped, and what your gift will do. YouCanGiveBack does not endorse or grade organizations.

Money

Financial picture

Tax year 2024

A plain-language look at the latest Form 990 figures available. These numbers help you ask better questions; they do not, by themselves, rate whether a charity is good or bad.

$100revenue

How each $100 of revenue was used

The large number compares each expense with revenue. The smaller number shows its share of total expenses.

Total reported revenue$16,914,337

Mission workProgram services$11,680,45169.06% of revenue80.1% of expenses

ManagementOffice and general costs$2,075,81512.27% of revenue14.2% of expenses

FundraisingAsking for donations$822,8604.86% of revenue5.6% of expenses

Revenue left after expensesReported annual surplus$2,335,21113.81% of revenueShown in gray on the chart

Total expenses$14,579,12686.19% of revenue

Gray means reported revenue left after expenses for this filing year. It does not necessarily mean cash sitting in a bank account.

Has the pattern changed?

Colored bars = expense mix: how each year’s expenses were divided. Total expenses vs. revenue shows whether the charity spent less or more than it received. The current filing is first.

YearExpense mixDetails

2024CurrentExpense mix: 80.1% mission · 14.2% management · 5.6% fundraisingTotal expenses: 86.19% of revenue

2023Expense mix: 81.7% mission · 13.2% management · 5.1% fundraisingTotal expenses: 84.02% of revenue

2022Expense mix: 81.9% mission · 13.2% management · 5.0% fundraisingTotal expenses: 87.79% of revenue

2021Expense mix: 78.0% mission · 16.2% management · 5.7% fundraisingTotal expenses: 69.08% of revenue

2020Expense mix: 74.6% mission · 22.0% management · 3.5% fundraisingTotal expenses: 69.23% of revenue

2019Expense mix: 76.9% mission · 23.1% management · 0.0% fundraisingTotal expenses: 72.08% of revenue

2018Expense mix: 75.0% mission · 25.0% management · 0.0% fundraisingTotal expenses: 68.91% of revenue

2017Expense mix: 85.9% mission · 14.1% management · 0.0% fundraisingTotal expenses: 63.74% of revenue

Money in and money out

Revenue$16,914,337

Expenses$14,579,126

Annual surplus $2,335,211 Revenue was higher than expenses for this filing year.

Reported spending amounts

Mission work means the Form 990 category called program services. These are reported accounting categories—not an independent measurement of results.

Mission work (program services)$11,680,451 · 80.1% of expenses

Management and office costs$2,075,815 · 14.2% of expenses

Fundraising$822,860 · 5.6% of expenses

See all reported dollar amounts

Revenue$16,914,337

Expenses$14,579,126

Assets$27,046,811

Income$16,914,337

Contributions$229,856

Mission work (program services)$11,680,451

Fundraising$822,860

Grants given$5,287,500

Average grant$78,918

Management and general$2,075,815

Stocks and bonds$23,855,045

Accounting fees$86,164

Investing fees$84,516

People

Leadership and board

Tax year 2024

Names, titles, time, and compensation below are reported by the organization on its Form 990.

People reported as paid

Person and titleCompensation

DAVID BARRETTEXECUTIVE DIRECTOR · 40 hrs/week $618,447Base $577,778 · Other $40,669

MARGARITA LEA VALDEZEMPLOYEE · 40 hrs/week $249,666Base $242,394 · Other $7,272

LAURA MICHELLE GALLAGHEREMPLOYEE · 40 hrs/week $231,223Base $215,407 · Other $15,816

RYAN HIETPASEMPLOYEE · 40 hrs/week $184,848Base $169,899 · Other $14,949

KELLIE BEUMEREMPLOYEE · 40 hrs/week $172,994Base $153,501 · Other $19,493

JEAN NORTONEMPLOYEE · 40 hrs/week $163,409Base $139,261 · Other $24,148

Compensation alone does not tell whether pay is reasonable. Consider the charity’s size, work, location, and results.

See everyone listed on the board or leadership roster (25)

DAVID BARRETTEXECUTIVE DIRECTOR

MARGARITA LEA VALDEZEMPLOYEE

LAURA MICHELLE GALLAGHEREMPLOYEE

RYAN HIETPASEMPLOYEE

KELLIE BEUMEREMPLOYEE

JEAN NORTONEMPLOYEE

TERENCE R FLOTTE MDPRESIDENT ELECT

ARAVIND ASOKAN PHDDIRECTOR

RAYNE H ROUCE MDPART YEAR DIRECTOR

PUNAM MALIK MDDIRECTOR

PAULA CANNON PHDPRESIDENT

MIGUEL SENA-ESTEVES PHDPART YEAR DIRECTOR

MATTHEW PORTEUS MD PHDVICE PRESIDENT

MARIA-GRAZIA RONCAROLO MDPART YEAR DIRECTOR

LINDSEY GEORGE MDDIRECTOR

KIMBERLY GOODSPEED MDPART YEAR DIRECTOR

KAH-WHYE PENG PHDDIRECTOR

JENNIFER WELLMAN MSDIRECTOR

JEFFREY S CHAMBERLAIN PHDPAST PRESIDENT

ISABELLE RIVIRE PHDSECRETARY

HILDEGARD BUNING PHDPART YEAR DIRECTOR

HANS-PETER KIEM MD PHDPAST PRESIDENT

FEDERICO MINGOZZI PHDTREASURER

DANIEL E BAUER MD PHDDIRECTOR

CLAIRE BOOTH MBBS PHDPART YEAR DIRECTOR

About this charity

Recognized since: January 1997
Location: 20700 SWENSON DR STE 200, WAUKESHA, WI 53186-0904
County: Waukesha
In care of: % DR GEORGE STAMATOYANNOPOULOS PRES
Primary officer: FEDERICO MINGOZZI PHD, TREASURER

How to reach them

WebsiteVisit the charity’s website Emailinfo@asgct.org Phone(414) 278-1341

Filing and classification

Latest tax year: 2024
Tax period began: January 1, 2024
Return type: 990
Tax preparer: RITZ HOLMAN LLP
NTEE classification: Birth Defects & Genetic Diseases Research (H20)
IRS tax category: Birth Defects & Genetic Diseases Research
Grant-giving organization: Yes